Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
7,533
archived clinical trials in
Chronic Obstructive Pulmonary Disease

Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated:  12/31/1969
Lowcountry Lung & Critical Care, PA
mi
from
Charleston, SC
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated: 12/31/1969
Lowcountry Lung & Critical Care, PA
mi
from
Charleston, SC
Click here to add this to my saved trials
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated:  12/31/1969
Neem Research Group
mi
from
Columbia, SC
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated: 12/31/1969
Neem Research Group
mi
from
Columbia, SC
Click here to add this to my saved trials
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated:  12/31/1969
Gaffney Pharmaceutical Research
mi
from
Gaffney, SC
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated: 12/31/1969
Gaffney Pharmaceutical Research
mi
from
Gaffney, SC
Click here to add this to my saved trials
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated:  12/31/1969
Greenville Pharmaceutical Research
mi
from
Greenville, SC
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated: 12/31/1969
Greenville Pharmaceutical Research
mi
from
Greenville, SC
Click here to add this to my saved trials
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated:  12/31/1969
Clinical Research of Rock Hill
mi
from
Rock Hill, SC
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated: 12/31/1969
Clinical Research of Rock Hill
mi
from
Rock Hill, SC
Click here to add this to my saved trials
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated:  12/31/1969
Spartanburg Medical Research
mi
from
Spartanburg, SC
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated: 12/31/1969
Spartanburg Medical Research
mi
from
Spartanburg, SC
Click here to add this to my saved trials
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated:  12/31/1969
Pioneer Research Solutions
mi
from
Sugar Land, TX
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated: 12/31/1969
Pioneer Research Solutions
mi
from
Sugar Land, TX
Click here to add this to my saved trials
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated:  12/31/1969
Pulmonary Associates of Richmond, Inc
mi
from
Richmond, VA
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated: 12/31/1969
Pulmonary Associates of Richmond, Inc
mi
from
Richmond, VA
Click here to add this to my saved trials
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated:  12/31/1969
Zain Research LLC
mi
from
Richland, WA
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated: 12/31/1969
Zain Research LLC
mi
from
Richland, WA
Click here to add this to my saved trials
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated:  12/31/1969
Research Alliance
mi
from
Saint Petersburg, FL
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated: 12/31/1969
Research Alliance
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated:  12/31/1969
Bassette Medical Research Inc.
mi
from
Sebring, FL
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated: 12/31/1969
Bassette Medical Research Inc.
mi
from
Sebring, FL
Click here to add this to my saved trials
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated:  12/31/1969
Physician HealthCare Network, PC
mi
from
Port Huron, MI
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated: 12/31/1969
Physician HealthCare Network, PC
mi
from
Port Huron, MI
Click here to add this to my saved trials
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated:  12/31/1969
University Hospitals at Case Medical Center
mi
from
Cleveland, OH
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
A Placebo-Controlled, Double-Blind, Parallel, Randomized, Two-Part, Clinical Dose-Confirming Study Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) On Long Term Oxygen Therapy (LTOT) INHALE 1
Status: Enrolling
Updated: 12/31/1969
University Hospitals at Case Medical Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Early Warning System
Comparing an Early Warning Alert With a Standardized Triage Intervention to Standard Care for the Management of Hospitalized Patients on General Hospital Wards.
Status: Enrolling
Updated:  12/31/1969
Barnes Jewish Hospital
mi
from
Saint Louis, MO
Early Warning System
Comparing an Early Warning Alert With a Standardized Triage Intervention to Standard Care for the Management of Hospitalized Patients on General Hospital Wards.
Status: Enrolling
Updated: 12/31/1969
Barnes Jewish Hospital
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Doxycycline for COPD in HIV-Infected Patients
Doxycycline for COPD in HIV-Infected Patients
Status: Enrolling
Updated:  12/31/1969
Genetic Medicine
mi
from
New York, NY
Doxycycline for COPD in HIV-Infected Patients
Doxycycline for COPD in HIV-Infected Patients
Status: Enrolling
Updated: 12/31/1969
Genetic Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Differentiating the Effects of Substance P and Beta-endorphin
Differentiating the Effects of Substance P and Beta-endorphin in the Perception of Breathlessness During Resistive Load Breathing in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated:  12/31/1969
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Differentiating the Effects of Substance P and Beta-endorphin
Differentiating the Effects of Substance P and Beta-endorphin in the Perception of Breathlessness During Resistive Load Breathing in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated: 12/31/1969
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
A Phase I Study of iPS Cell Generation From Patients With COPD
A Phase I Study of iPS Cell Generation From Patients With COPD
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic Rochester
mi
from
Rochester, MN
A Phase I Study of iPS Cell Generation From Patients With COPD
A Phase I Study of iPS Cell Generation From Patients With COPD
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Tadalafil for Pulmonary Hypertension Due to Chronic Lung Disease
Tadalafil for Pulmonary Hypertension Associated With Chronic Lung Disease
Status: Enrolling
Updated:  12/31/1969
VA Greater Los Angeles Healthcare System, West Los Angeles, CA
mi
from
West Los Angeles, CA
Tadalafil for Pulmonary Hypertension Due to Chronic Lung Disease
Tadalafil for Pulmonary Hypertension Associated With Chronic Lung Disease
Status: Enrolling
Updated: 12/31/1969
VA Greater Los Angeles Healthcare System, West Los Angeles, CA
mi
from
West Los Angeles, CA
Click here to add this to my saved trials
Tadalafil for Pulmonary Hypertension Due to Chronic Lung Disease
Tadalafil for Pulmonary Hypertension Associated With Chronic Lung Disease
Status: Enrolling
Updated:  12/31/1969
VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
mi
from
Boston, MA
Tadalafil for Pulmonary Hypertension Due to Chronic Lung Disease
Tadalafil for Pulmonary Hypertension Associated With Chronic Lung Disease
Status: Enrolling
Updated: 12/31/1969
VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
mi
from
Boston, MA
Click here to add this to my saved trials
Tadalafil for Pulmonary Hypertension Due to Chronic Lung Disease
Tadalafil for Pulmonary Hypertension Associated With Chronic Lung Disease
Status: Enrolling
Updated:  12/31/1969
Providence VA Medical Center, Providence, RI
mi
from
Providence, RI
Tadalafil for Pulmonary Hypertension Due to Chronic Lung Disease
Tadalafil for Pulmonary Hypertension Associated With Chronic Lung Disease
Status: Enrolling
Updated: 12/31/1969
Providence VA Medical Center, Providence, RI
mi
from
Providence, RI
Click here to add this to my saved trials
Tadalafil for Pulmonary Hypertension Due to Chronic Lung Disease
Tadalafil for Pulmonary Hypertension Associated With Chronic Lung Disease
Status: Enrolling
Updated:  12/31/1969
VA Eastern Colorado Health Care System, Denver, CO
mi
from
Denver, CO
Tadalafil for Pulmonary Hypertension Due to Chronic Lung Disease
Tadalafil for Pulmonary Hypertension Associated With Chronic Lung Disease
Status: Enrolling
Updated: 12/31/1969
VA Eastern Colorado Health Care System, Denver, CO
mi
from
Denver, CO
Click here to add this to my saved trials
Tadalafil for Pulmonary Hypertension Due to Chronic Lung Disease
Tadalafil for Pulmonary Hypertension Associated With Chronic Lung Disease
Status: Enrolling
Updated:  12/31/1969
Atlanta VA Medical and Rehab Center, Decatur, GA
mi
from
Decatur, GA
Tadalafil for Pulmonary Hypertension Due to Chronic Lung Disease
Tadalafil for Pulmonary Hypertension Associated With Chronic Lung Disease
Status: Enrolling
Updated: 12/31/1969
Atlanta VA Medical and Rehab Center, Decatur, GA
mi
from
Decatur, GA
Click here to add this to my saved trials
Pulmonx Endobronchial Valves Used in Treatment of Emphysema (LIBERATE Study)
Lung Function Improvement After Bronchoscopic Lung Volume Reduction With Pulmonx Endobronchial Valves Used in Treatment of Emphysema
Status: Enrolling
Updated:  12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Pulmonx Endobronchial Valves Used in Treatment of Emphysema (LIBERATE Study)
Lung Function Improvement After Bronchoscopic Lung Volume Reduction With Pulmonx Endobronchial Valves Used in Treatment of Emphysema
Status: Enrolling
Updated: 12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Pulmonx Endobronchial Valves Used in Treatment of Emphysema (LIBERATE Study)
Lung Function Improvement After Bronchoscopic Lung Volume Reduction With Pulmonx Endobronchial Valves Used in Treatment of Emphysema
Status: Enrolling
Updated:  12/31/1969
Arizona Pulmonary Specialists, Ltd.
mi
from
Phoenix, AZ
Pulmonx Endobronchial Valves Used in Treatment of Emphysema (LIBERATE Study)
Lung Function Improvement After Bronchoscopic Lung Volume Reduction With Pulmonx Endobronchial Valves Used in Treatment of Emphysema
Status: Enrolling
Updated: 12/31/1969
Arizona Pulmonary Specialists, Ltd.
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Pulmonx Endobronchial Valves Used in Treatment of Emphysema (LIBERATE Study)
Lung Function Improvement After Bronchoscopic Lung Volume Reduction With Pulmonx Endobronchial Valves Used in Treatment of Emphysema
Status: Enrolling
Updated:  12/31/1969
University of Southern California
mi
from
Los Angeles, CA
Pulmonx Endobronchial Valves Used in Treatment of Emphysema (LIBERATE Study)
Lung Function Improvement After Bronchoscopic Lung Volume Reduction With Pulmonx Endobronchial Valves Used in Treatment of Emphysema
Status: Enrolling
Updated: 12/31/1969
University of Southern California
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Pulmonx Endobronchial Valves Used in Treatment of Emphysema (LIBERATE Study)
Lung Function Improvement After Bronchoscopic Lung Volume Reduction With Pulmonx Endobronchial Valves Used in Treatment of Emphysema
Status: Enrolling
Updated:  12/31/1969
University of California, Davis Medical Center
mi
from
Sacramento, CA
Pulmonx Endobronchial Valves Used in Treatment of Emphysema (LIBERATE Study)
Lung Function Improvement After Bronchoscopic Lung Volume Reduction With Pulmonx Endobronchial Valves Used in Treatment of Emphysema
Status: Enrolling
Updated: 12/31/1969
University of California, Davis Medical Center
mi
from
Sacramento, CA
Click here to add this to my saved trials
Pulmonx Endobronchial Valves Used in Treatment of Emphysema (LIBERATE Study)
Lung Function Improvement After Bronchoscopic Lung Volume Reduction With Pulmonx Endobronchial Valves Used in Treatment of Emphysema
Status: Enrolling
Updated:  12/31/1969
University of California at San Francisco
mi
from
San Francisco, CA
Pulmonx Endobronchial Valves Used in Treatment of Emphysema (LIBERATE Study)
Lung Function Improvement After Bronchoscopic Lung Volume Reduction With Pulmonx Endobronchial Valves Used in Treatment of Emphysema
Status: Enrolling
Updated: 12/31/1969
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Pulmonx Endobronchial Valves Used in Treatment of Emphysema (LIBERATE Study)
Lung Function Improvement After Bronchoscopic Lung Volume Reduction With Pulmonx Endobronchial Valves Used in Treatment of Emphysema
Status: Enrolling
Updated:  12/31/1969
Stanford University
mi
from
Stanford, CA
Pulmonx Endobronchial Valves Used in Treatment of Emphysema (LIBERATE Study)
Lung Function Improvement After Bronchoscopic Lung Volume Reduction With Pulmonx Endobronchial Valves Used in Treatment of Emphysema
Status: Enrolling
Updated: 12/31/1969
Stanford University
mi
from
Stanford, CA
Click here to add this to my saved trials
Pulmonx Endobronchial Valves Used in Treatment of Emphysema (LIBERATE Study)
Lung Function Improvement After Bronchoscopic Lung Volume Reduction With Pulmonx Endobronchial Valves Used in Treatment of Emphysema
Status: Enrolling
Updated:  12/31/1969
Los Angeles Biomedical Research Institute at Harbor UCLA Medical Center
mi
from
Torrance, CA
Pulmonx Endobronchial Valves Used in Treatment of Emphysema (LIBERATE Study)
Lung Function Improvement After Bronchoscopic Lung Volume Reduction With Pulmonx Endobronchial Valves Used in Treatment of Emphysema
Status: Enrolling
Updated: 12/31/1969
Los Angeles Biomedical Research Institute at Harbor UCLA Medical Center
mi
from
Torrance, CA
Click here to add this to my saved trials
Pulmonx Endobronchial Valves Used in Treatment of Emphysema (LIBERATE Study)
Lung Function Improvement After Bronchoscopic Lung Volume Reduction With Pulmonx Endobronchial Valves Used in Treatment of Emphysema
Status: Enrolling
Updated:  12/31/1969
Orlando Health
mi
from
Orlando, FL
Pulmonx Endobronchial Valves Used in Treatment of Emphysema (LIBERATE Study)
Lung Function Improvement After Bronchoscopic Lung Volume Reduction With Pulmonx Endobronchial Valves Used in Treatment of Emphysema
Status: Enrolling
Updated: 12/31/1969
Orlando Health
mi
from
Orlando, FL
Click here to add this to my saved trials
Pulmonx Endobronchial Valves Used in Treatment of Emphysema (LIBERATE Study)
Lung Function Improvement After Bronchoscopic Lung Volume Reduction With Pulmonx Endobronchial Valves Used in Treatment of Emphysema
Status: Enrolling
Updated:  12/31/1969
University of Louisville Research Foundation, Inc.
mi
from
Louisville, KY
Pulmonx Endobronchial Valves Used in Treatment of Emphysema (LIBERATE Study)
Lung Function Improvement After Bronchoscopic Lung Volume Reduction With Pulmonx Endobronchial Valves Used in Treatment of Emphysema
Status: Enrolling
Updated: 12/31/1969
University of Louisville Research Foundation, Inc.
mi
from
Louisville, KY
Click here to add this to my saved trials
Pulmonx Endobronchial Valves Used in Treatment of Emphysema (LIBERATE Study)
Lung Function Improvement After Bronchoscopic Lung Volume Reduction With Pulmonx Endobronchial Valves Used in Treatment of Emphysema
Status: Enrolling
Updated:  12/31/1969
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Pulmonx Endobronchial Valves Used in Treatment of Emphysema (LIBERATE Study)
Lung Function Improvement After Bronchoscopic Lung Volume Reduction With Pulmonx Endobronchial Valves Used in Treatment of Emphysema
Status: Enrolling
Updated: 12/31/1969
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Pulmonx Endobronchial Valves Used in Treatment of Emphysema (LIBERATE Study)
Lung Function Improvement After Bronchoscopic Lung Volume Reduction With Pulmonx Endobronchial Valves Used in Treatment of Emphysema
Status: Enrolling
Updated:  12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Pulmonx Endobronchial Valves Used in Treatment of Emphysema (LIBERATE Study)
Lung Function Improvement After Bronchoscopic Lung Volume Reduction With Pulmonx Endobronchial Valves Used in Treatment of Emphysema
Status: Enrolling
Updated: 12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Pulmonx Endobronchial Valves Used in Treatment of Emphysema (LIBERATE Study)
Lung Function Improvement After Bronchoscopic Lung Volume Reduction With Pulmonx Endobronchial Valves Used in Treatment of Emphysema
Status: Enrolling
Updated:  12/31/1969
Cleveland Clinic
mi
from
Cleveland, OH
Pulmonx Endobronchial Valves Used in Treatment of Emphysema (LIBERATE Study)
Lung Function Improvement After Bronchoscopic Lung Volume Reduction With Pulmonx Endobronchial Valves Used in Treatment of Emphysema
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Pulmonx Endobronchial Valves Used in Treatment of Emphysema (LIBERATE Study)
Lung Function Improvement After Bronchoscopic Lung Volume Reduction With Pulmonx Endobronchial Valves Used in Treatment of Emphysema
Status: Enrolling
Updated:  12/31/1969
Temple University Hospital
mi
from
Philadelphia, PA
Pulmonx Endobronchial Valves Used in Treatment of Emphysema (LIBERATE Study)
Lung Function Improvement After Bronchoscopic Lung Volume Reduction With Pulmonx Endobronchial Valves Used in Treatment of Emphysema
Status: Enrolling
Updated: 12/31/1969
Temple University Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Pulmonx Endobronchial Valves Used in Treatment of Emphysema (LIBERATE Study)
Lung Function Improvement After Bronchoscopic Lung Volume Reduction With Pulmonx Endobronchial Valves Used in Treatment of Emphysema
Status: Enrolling
Updated:  12/31/1969
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Pulmonx Endobronchial Valves Used in Treatment of Emphysema (LIBERATE Study)
Lung Function Improvement After Bronchoscopic Lung Volume Reduction With Pulmonx Endobronchial Valves Used in Treatment of Emphysema
Status: Enrolling
Updated: 12/31/1969
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Pulmonx Endobronchial Valves Used in Treatment of Emphysema (LIBERATE Study)
Lung Function Improvement After Bronchoscopic Lung Volume Reduction With Pulmonx Endobronchial Valves Used in Treatment of Emphysema
Status: Enrolling
Updated:  12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Pulmonx Endobronchial Valves Used in Treatment of Emphysema (LIBERATE Study)
Lung Function Improvement After Bronchoscopic Lung Volume Reduction With Pulmonx Endobronchial Valves Used in Treatment of Emphysema
Status: Enrolling
Updated: 12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Pulmonx Endobronchial Valves Used in Treatment of Emphysema (LIBERATE Study)
Lung Function Improvement After Bronchoscopic Lung Volume Reduction With Pulmonx Endobronchial Valves Used in Treatment of Emphysema
Status: Enrolling
Updated:  12/31/1969
Houston Methodist Hospital
mi
from
Houston, TX
Pulmonx Endobronchial Valves Used in Treatment of Emphysema (LIBERATE Study)
Lung Function Improvement After Bronchoscopic Lung Volume Reduction With Pulmonx Endobronchial Valves Used in Treatment of Emphysema
Status: Enrolling
Updated: 12/31/1969
Houston Methodist Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Pulmonx Endobronchial Valves Used in Treatment of Emphysema (LIBERATE Study)
Lung Function Improvement After Bronchoscopic Lung Volume Reduction With Pulmonx Endobronchial Valves Used in Treatment of Emphysema
Status: Enrolling
Updated:  12/31/1969
Hospital de Clinicas Porto Alegre
mi
from
Porto Alegre,
Pulmonx Endobronchial Valves Used in Treatment of Emphysema (LIBERATE Study)
Lung Function Improvement After Bronchoscopic Lung Volume Reduction With Pulmonx Endobronchial Valves Used in Treatment of Emphysema
Status: Enrolling
Updated: 12/31/1969
Hospital de Clinicas Porto Alegre
mi
from
Porto Alegre,
Click here to add this to my saved trials
Pulmonx Endobronchial Valves Used in Treatment of Emphysema (LIBERATE Study)
Lung Function Improvement After Bronchoscopic Lung Volume Reduction With Pulmonx Endobronchial Valves Used in Treatment of Emphysema
Status: Enrolling
Updated:  12/31/1969
El Camino Hospital
mi
from
Mountain View, CA
Pulmonx Endobronchial Valves Used in Treatment of Emphysema (LIBERATE Study)
Lung Function Improvement After Bronchoscopic Lung Volume Reduction With Pulmonx Endobronchial Valves Used in Treatment of Emphysema
Status: Enrolling
Updated: 12/31/1969
El Camino Hospital
mi
from
Mountain View, CA
Click here to add this to my saved trials
Improving Communication About Serious Illness
Health System Intervention to Improve Communication About End-of-Life Care for Vulnerable Patients
Status: Enrolling
Updated:  12/31/1969
Valley Medical Center
mi
from
Renton, WA
Improving Communication About Serious Illness
Health System Intervention to Improve Communication About End-of-Life Care for Vulnerable Patients
Status: Enrolling
Updated: 12/31/1969
Valley Medical Center
mi
from
Renton, WA
Click here to add this to my saved trials
Improving Communication About Serious Illness
Health System Intervention to Improve Communication About End-of-Life Care for Vulnerable Patients
Status: Enrolling
Updated:  12/31/1969
Harborview Medical Center
mi
from
Seattle, WA
Improving Communication About Serious Illness
Health System Intervention to Improve Communication About End-of-Life Care for Vulnerable Patients
Status: Enrolling
Updated: 12/31/1969
Harborview Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Improving Communication About Serious Illness
Health System Intervention to Improve Communication About End-of-Life Care for Vulnerable Patients
Status: Enrolling
Updated:  12/31/1969
Swedish Medical Center
mi
from
Seattle, WA
Improving Communication About Serious Illness
Health System Intervention to Improve Communication About End-of-Life Care for Vulnerable Patients
Status: Enrolling
Updated: 12/31/1969
Swedish Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Improving Communication About Serious Illness
Health System Intervention to Improve Communication About End-of-Life Care for Vulnerable Patients
Status: Enrolling
Updated:  12/31/1969
Northwest Hospital and Medical Center
mi
from
Seattle, WA
Improving Communication About Serious Illness
Health System Intervention to Improve Communication About End-of-Life Care for Vulnerable Patients
Status: Enrolling
Updated: 12/31/1969
Northwest Hospital and Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Improving Communication About Serious Illness
Health System Intervention to Improve Communication About End-of-Life Care for Vulnerable Patients
Status: Enrolling
Updated:  12/31/1969
University of Washington Medical Center
mi
from
Seattle, WA
Improving Communication About Serious Illness
Health System Intervention to Improve Communication About End-of-Life Care for Vulnerable Patients
Status: Enrolling
Updated: 12/31/1969
University of Washington Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Improving Communication About Serious Illness
Health System Intervention to Improve Communication About End-of-Life Care for Vulnerable Patients
Status: Enrolling
Updated:  12/31/1969
UW Neighborhood Clinics
mi
from
Seattle, WA
Improving Communication About Serious Illness
Health System Intervention to Improve Communication About End-of-Life Care for Vulnerable Patients
Status: Enrolling
Updated: 12/31/1969
UW Neighborhood Clinics
mi
from
Seattle, WA
Click here to add this to my saved trials
Portable Oxygen Concentrator to Improve Quality of Life in Chronic Obstructive Pulmonary Disease
A Study to Evaluate Improvement in the Quality of Life and Outcomes of Patients Diagnosed With Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated:  12/31/1969
Tri-City Pulmonary Medical Group
mi
from
Oceanside, CA
Portable Oxygen Concentrator to Improve Quality of Life in Chronic Obstructive Pulmonary Disease
A Study to Evaluate Improvement in the Quality of Life and Outcomes of Patients Diagnosed With Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated: 12/31/1969
Tri-City Pulmonary Medical Group
mi
from
Oceanside, CA
Click here to add this to my saved trials
Portable Oxygen Concentrator to Improve Quality of Life in Chronic Obstructive Pulmonary Disease
A Study to Evaluate Improvement in the Quality of Life and Outcomes of Patients Diagnosed With Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated:  12/31/1969
Cardinal Medical Group
mi
from
Vista, CA
Portable Oxygen Concentrator to Improve Quality of Life in Chronic Obstructive Pulmonary Disease
A Study to Evaluate Improvement in the Quality of Life and Outcomes of Patients Diagnosed With Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated: 12/31/1969
Cardinal Medical Group
mi
from
Vista, CA
Click here to add this to my saved trials
Portable Oxygen Concentrator to Improve Quality of Life in Chronic Obstructive Pulmonary Disease
A Study to Evaluate Improvement in the Quality of Life and Outcomes of Patients Diagnosed With Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated:  12/31/1969
Pathway Medical Group
mi
from
Westminster, CA
Portable Oxygen Concentrator to Improve Quality of Life in Chronic Obstructive Pulmonary Disease
A Study to Evaluate Improvement in the Quality of Life and Outcomes of Patients Diagnosed With Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated: 12/31/1969
Pathway Medical Group
mi
from
Westminster, CA
Click here to add this to my saved trials
Safety and Clinical Outcomes Study: SVF Deployment for Orthopedic, Neurologic, Urologic, and Cardio-pulmonary Conditions
Clinical Intervention Study: Adverse Events and Clinical Outcomes for the Deployment of Adipose Derived SVF (Rich in Adult Stem Cells and Growth Factors)for Select Orthopedic, Neurologic, Urologic, and Cardio-Pulmonary Conditions.
Status: Enrolling
Updated:  12/31/1969
California Stem Cell Treatment Center
mi
from
Rancho Mirage, CA
Safety and Clinical Outcomes Study: SVF Deployment for Orthopedic, Neurologic, Urologic, and Cardio-pulmonary Conditions
Clinical Intervention Study: Adverse Events and Clinical Outcomes for the Deployment of Adipose Derived SVF (Rich in Adult Stem Cells and Growth Factors)for Select Orthopedic, Neurologic, Urologic, and Cardio-Pulmonary Conditions.
Status: Enrolling
Updated: 12/31/1969
California Stem Cell Treatment Center
mi
from
Rancho Mirage, CA
Click here to add this to my saved trials